ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness

NCT00484471 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: aripiprazole
DRUG: valproate
DRUG: placebo

Sponsor

Korea Otsuka International Asia Arab